Brentjens RJ - Search Results

1

Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.

Amini L, Silbert SK, Maude SL, Nastoupil LJ, Ramos CA, Brentjens RJ, Sauter CS, Shah NN, Abou-El-Enein M. Amini L, et al. Among authors: brentjens rj. Nat Rev Clin Oncol. 2022 May;19(5):342-355. doi: 10.1038/s41571-022-00607-3. Epub 2022 Mar 22. Nat Rev Clin Oncol. 2022. PMID: 35318469 Review.

2

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

Brentjens RJ, Latouche JB, Santos E, Marti F, Gong MC, Lyddane C, King PD, Larson S, Weiss M, Rivière I, Sadelain M. Brentjens RJ, et al. Nat Med. 2003 Mar;9(3):279-86. doi: 10.1038/nm827. Epub 2003 Feb 10. Nat Med. 2003. PMID: 12579196

3

Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy.

Hollyman D, Stefanski J, Przybylowski M, Bartido S, Borquez-Ojeda O, Taylor C, Yeh R, Capacio V, Olszewska M, Hosey J, Sadelain M, Brentjens RJ, Rivière I. Hollyman D, et al. Among authors: brentjens rj. J Immunother. 2009 Feb-Mar;32(2):169-80. doi: 10.1097/CJI.0b013e318194a6e8. J Immunother. 2009. PMID: 19238016 Free PMC article.

4

Cellular therapies in acute lymphoblastic leukemia.

Brentjens RJ. Brentjens RJ. Curr Opin Mol Ther. 2009 Aug;11(4):375-82. Curr Opin Mol Ther. 2009. PMID: 19649982 Free PMC article. Review.

5

Adoptive T cell immunotherapy strategies for the treatment of patients with ovarian cancer.

Chekmasova AA, Brentjens RJ. Chekmasova AA, et al. Among authors: brentjens rj. Discov Med. 2010 Jan;9(44):62-70. Discov Med. 2010. PMID: 20102688 Free article. Review.

6

Cellular therapies in acute lymphoblastic leukemia.

Park JH, Sauter C, Brentjens R. Park JH, et al. Hematol Oncol Clin North Am. 2011 Dec;25(6):1281-301. doi: 10.1016/j.hoc.2011.09.015. Hematol Oncol Clin North Am. 2011. PMID: 22093587 Free PMC article. Review.

7

Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen.

Brentjens RJ, Curran KJ. Brentjens RJ, et al. Hematology Am Soc Hematol Educ Program. 2012;2012:143-51. doi: 10.1182/asheducation-2012.1.143. Hematology Am Soc Hematol Educ Program. 2012. PMID: 23233573 Free PMC article. Review.

8

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.

Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG, Bartido S, Stefanski J, Taylor C, Olszewska M, Borquez-Ojeda O, Qu J, Wasielewska T, He Q, Bernal Y, Rijo IV, Hedvat C, Kobos R, Curran K, Steinherz P, Jurcic J, Rosenblat T, Maslak P, Frattini M, Sadelain M. Brentjens RJ, et al. Sci Transl Med. 2013 Mar 20;5(177):177ra38. doi: 10.1126/scitranslmed.3005930. Sci Transl Med. 2013. PMID: 23515080 Free PMC article. Clinical Trial.

9

Chimeric antigen receptor therapy for chronic lymphocytic leukemia: what are the challenges?

Davila ML, Brentjens R. Davila ML, et al. Hematol Oncol Clin North Am. 2013 Apr;27(2):341-53. doi: 10.1016/j.hoc.2012.12.004. Hematol Oncol Clin North Am. 2013. PMID: 23561477 Free PMC article. Review.

10

Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies.

Davila ML, Bouhassira DC, Park JH, Curran KJ, Smith EL, Pegram HJ, Brentjens R. Davila ML, et al. Int J Hematol. 2014 Apr;99(4):361-71. doi: 10.1007/s12185-013-1479-5. Epub 2013 Dec 6. Int J Hematol. 2014. PMID: 24311149 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters